Today: 4 April 2026
Subscribe
Browse Category

Stock Market 27 October 2025

Intellia Therapeutics Stock Plummets 45% After CRISPR Trial Shock – Can Gene-Editing Hopes Survive?

Intellia Therapeutics Stock Plummets 45% After CRISPR Trial Shock – Can Gene-Editing Hopes Survive?

Intellia Therapeutics shares plunged nearly 45% Monday after the company halted two Phase 3 trials of its CRISPR therapy NTLA-2001 due to a severe liver injury in a patient. The stock dropped from about $19 to the low teens, with CRISPR Therapeutics also falling 10%. Intellia paused dosing and enrollment following the Grade 4 liver event and is consulting regulators on next steps.
27 October 2025
···
Lithium Americas Stock Skyrockets on U.S. ‘White Gold’ Deal – Experts Weigh In

Lithium Americas (LAC) Stock Soars on U.S. ‘White Gold’ Stake Amid EV Boom – What’s Next?

Lithium Americas Corp. shares surged over 200% in 2025 after the U.S. Department of Energy agreed to take equity stakes and provide a $2.2 billion loan for its Thacker Pass lithium project. The stock peaked above $10 in October before retreating to $6.72 on Oct. 24. Construction at Thacker Pass began after a $435 million initial loan drawdown. Analyst price targets remain below current levels.
27 October 2025
····
Rigetti’s Quantum Leap: Stock Jumps 5,000% and Then Grinds Back – Bubble or Breakthrough?

Rigetti’s Quantum Stock Explosion: 5,000% Surge, Sudden Slump, and What’s Next for RGTI

Rigetti Computing shares soared nearly 5,000% in 2025, peaking at $56 in mid-October before dropping to around $40 by late month. The stock jumped again after reports the Trump administration may take stakes in quantum firms, though officials denied talks. Rigetti’s valuation neared $17 billion despite annual revenue under $10 million. Analysts rate it a “Buy” but set price targets far below recent highs.
27 October 2025
··
Big Money Piles into Qualcomm: New AI Chip Breakthroughs Ignite Stock Surge

Big Money Piles into Qualcomm: New AI Chip Breakthroughs Ignite Stock Surge

Qualcomm stock jumped over 10% to a 52-week high near $182 on Oct. 27 after launching new AI data-center chips to compete with Nvidia. Major institutions, including Bessemer Group and UTIMCO, increased stakes in Q2. Last quarter’s earnings beat forecasts with $2.77 EPS and $10.37 billion revenue. Analysts rate the stock a “Moderate Buy,” with price targets around $183.
27 October 2025
····
Unstoppable Vanguard Tech Fund Soars 50% on AI Boom – What Investors Need to Know

Unstoppable Vanguard Tech Fund Soars 50% on AI Boom – What Investors Need to Know

Vanguard’s Information Technology ETF (VGT) has jumped about 50% in six months, hitting record highs near $774 per share. Nvidia, Apple, and Microsoft now make up roughly 44% of the fund’s weight after sharp gains in 2025. AI-fueled demand for chips and cloud services has driven the rally. VGT’s price/earnings ratio has climbed to 41, well above the S&P 500’s 25, raising concerns about valuation risk.
27 October 2025
·····
Huntington Bancshares’ Bold Moves: Strong Earnings and a $7.4B Bank Takeover Shake Up HBAN Stock

Huntington Bancshares’ Bold Moves: Strong Earnings and a $7.4B Bank Takeover Shake Up HBAN Stock

Huntington Bancshares reported Q3 net income of $629 million, up 22% year-over-year, beating forecasts. The bank announced a $7.4 billion all-stock acquisition of Cadence Bank, expanding into Texas and the Southeast. HBAN shares fell 3–4% pre-market after the merger news, trading around $15. Shares remain about 15% below their 52-week high.
27 October 2025
··
CRISPR Therapeutics Stock Soars on Gene-Editing Breakthroughs, Then Stumbles – What’s Next for CRSP?

CRISPR Therapeutics Stock Soars on Gene-Editing Breakthroughs, Then Stumbles – What’s Next for CRSP?

CRISPR Therapeutics traded near $67 on Oct. 27, down 3% after safety concerns hit gene-editing stocks. Shares remain up nearly 100% in 2025, fueled by a major preclinical breakthrough and global rollout of its Casgevy therapy. Rival Intellia plunged 45% after a trial pause, dragging CRSP down 10% in sympathy. Analysts remain bullish, with targets up to $93 despite sector volatility.
27 October 2025
··
Dow Smashes 47,000 on Trade Truce Buzz – Fed Rate Cut Hopes Fuel Record Rally

Dow Smashes 47,000 on Trade Truce Buzz – Fed Rate Cut Hopes Fuel Record Rally

The Dow Jones closed above 47,000 for the first time Friday, jumping 473 points to 47,207. Markets are betting the Federal Reserve will cut rates by 0.25% at its meeting Wednesday. President Trump and China’s Xi are expected to finalize a “Phase One” trade deal this week. Microsoft, Alphabet, Meta, Apple, and Amazon report earnings as tech stocks drive the rally.
27 October 2025
······
Elon Musk Smashes Records by Hitting $500 Billion Net Worth—How He Got There and What It Means

Elon Musk’s $1 Trillion Tesla Pay Gambit: ‘Robot Army’ Ambitions, Shareholder Showdown & TSLA’s High-Stakes Future

Tesla shareholders will vote November 6 on a $1 trillion pay package for CEO Elon Musk, the largest ever proposed for a chief executive. The board warns Musk may leave if the plan is rejected, while proxy advisers call the deal excessive. If approved, Musk’s stake could rise to nearly 29% if Tesla meets targets, including a $8.5 trillion valuation by 2035. Some major investors have publicly criticized the proposal.
27 October 2025
···
Keurig Dr Pepper (KDP) Stock Soars on $18B Coffee Deal and Upgraded Forecast

Keurig Dr Pepper (KDP) Stock Soars on $18B Coffee Deal and Upgraded Forecast

Keurig Dr Pepper reported Q3 net sales of $4.31 billion, up 10.7% year-over-year, and announced an $18 billion takeover of JDE Peet’s. Management raised its 2025 net sales growth outlook and secured $7 billion in financing from Apollo and KKR. KDP shares jumped 5–6% in pre-market trading on Oct. 27 after the news. The stock remains near one-year lows but analysts see upside.
27 October 2025
·
American Water & Essential Utilities to Merge in $63B ‘Mega-Deal’ – What Investors Need to Know

American Water & Essential Utilities to Merge in $63B ‘Mega-Deal’ – What Investors Need to Know

American Water Works and Essential Utilities boards approved an all-stock merger on Oct. 26, 2025, creating a $40 billion utility serving 4.7 million connections in 17 states. The combined company will keep the American Water name and be led by AWK’s John C. Griffith as CEO. Essential shareholders receive a 10% premium; AWK holders will own 69% of the new firm. No immediate rate hikes are planned. The deal is expected to close by Q1 2027.
27 October 2025
···
Plug Power Stock’s Wild 170% Hydrogen Rally Cools – What’s Next for PLUG?

Plug Power Stock’s Wild 170% Hydrogen Rally Cools – What’s Next for PLUG?

Plug Power closed at $2.95 on October 27, 2025, after a volatile week and remains near double its summer lows. The company secured a $1.66 billion DOE loan guarantee, a $525 million credit facility, and raised $370 million in cash this month. Founder Andy Marsh will step down as CEO in March 2026, with José Luis Crespo set to take over. Analyst ratings range from “Strong Buy” to “Sell,” with a consensus target near current levels.
27 October 2025
··
AiRWA (YYAI) Soars on Crypto Pivot – Tiny Stock on a Wild Ride or Warning Sign?

YYAI Stock’s Wild Ride: $100M Crypto Pivot and 1-for-50 Reverse Split Shock Investors

YYAI (AiRWA Inc.) shares have plunged over 90% in 2025, trading near $4 post-split as of Oct. 27, with the market cap falling to just a few million dollars. The company executed a 1-for-50 reverse split to avoid Nasdaq delisting and shifted from sports-tech to blockchain finance after a $100 million joint venture with JuCoin Capital. Volatility spiked, with intraday swings over 1,000% and heavy insider buying. Analysts warn of extreme risk.
27 October 2025
··
Wolfspeed Stock’s Wild Comeback: From Bankruptcy to Boom – Will the Rally Last?

Wolfspeed Stock’s Wild Comeback: From Bankruptcy to Boom – Will the Rally Last?

Wolfspeed shares soared over 1000% after exiting bankruptcy in late September, trading near $29–30 with a market cap of $0.7–0.8 billion as of Oct. 27. The chipmaker cut 70% of its $6.5 billion debt and canceled old shares, leaving legacy holders with 3–5% of new equity. Most analysts rate the stock a Hold, with a $9 price target, citing ongoing losses and high volatility. Investors await fiscal Q1 results on Oct. 29.
27 October 2025
·
Euronext Paris Shocks Markets with Historic Roots, Surging Stocks & Bold 2025 Moves

CAC 40 Near Record High, Defies Moody’s Warning as Luxury Stocks Rally

France’s CAC 40 index held near 8,230 points Monday, flat and just below last week’s record. Moody’s cut France’s outlook to “negative,” but markets were unmoved. Kering surged 9% last week after better-than-feared sales, while Dassault Systèmes and STMicroelectronics dropped over 13% on weak guidance. The CAC 40 is up about 10% year-to-date.
27 October 2025
········
AT&T (T) Stock Skyrockets on Subscriber Boom – Will $30 Come Soon?

AT&T (T) Stock Skyrockets on Subscriber Boom – Will $30 Come Soon?

AT&T added 405,000 postpaid wireless subscribers in Q3 2025, beating expectations and lifting revenue 1.6% to $30.7 billion. Shares spiked 4% pre-market Oct. 22 but closed down 2%, trading near $25.14 by Oct. 27. The company reaffirmed full-year guidance and pays a 4.2% dividend yield. Wall Street consensus rates the stock a “Moderate Buy,” with average 12-month targets around $30–31.
27 October 2025
·
Rigetti’s (RGTI) Quantum Stock Skyrockets 5,000% – Bubble or Breakthrough Ahead?

Rigetti’s (RGTI) Quantum Stock Skyrockets 5,000% – Bubble or Breakthrough Ahead?

Rigetti Computing shares surged from under $1 to nearly $56 in October, closing at $39 on Oct. 24 after heavy volatility. The rally followed $11.5 million in new government and hardware contracts, and a new 36-qubit processor launch. The company’s market cap now stands near $18 billion on annual revenue of about $10 million. Analysts warn the stock is overextended, despite almost universal “Buy” ratings.
27 October 2025
····
Pfizer Stock Surges 15% on Trump’s Pricing Pact & $7.3B Obesity Deal – Can the Rally Last?

Pfizer (PFE) Stock Rebounds on Trump Drug Deal & Obesity Gamble – Can the Rally Last?

Pfizer shares traded near $24.76 on Oct. 24, up about 9% from their 52-week low but still down for the year. The stock jumped over 6% in late September after Pfizer reached a deal with the Trump administration to cut Medicaid drug prices, easing regulatory risk. Pfizer reports Q3 results Nov. 4, with analysts expecting lower earnings due to falling COVID product sales.
27 October 2025
··
Bubble or Boom? Magnificent Seven Stocks Face Critical Earnings Showdown

Bubble or Boom? Magnificent Seven Stocks Face Critical Earnings Showdown

The “Magnificent Seven” tech stocks now make up over one-third of the S&P 500’s market value after jumping about 35% in the past year, outpacing the index’s 15% gain. Apple hit a record high near $3.9 trillion, while Nvidia became the world’s most valuable company. The group’s Q3 earnings are expected to rise 15%. Tesla shares fell 2% after a mixed earnings report.
27 October 2025
········
1 … 1,276 1,277 1,278 1,279 1,280 … 1,371

Stock Market Today

  • Pembroke VCT Boosts Capital with B Share Allotment as Market Liquidity Rises
    April 4, 2026, 7:59 AM EDT. Pembroke VCT plc, a UK-listed venture capital trust, has allotted 5.18 million new B Ordinary Shares, raising fresh capital for its high-growth portfolio. The shares, priced at 100.2p based on unaudited net asset value as of December 2025, will trade on the London Stock Exchange around April 9, 2026. This move increases total B shares to nearly 299 million, enhancing market liquidity. The company's diversified venture investments benefit from this capital injection amid persistent negative free cash flow and volatile results. Analyst consensus holds a 'Hold' rating with a £94 price target. Pembroke VCT operates under the UK's FCA rules, targeting smaller, growth-oriented firms and providing investors tax advantages linked to venture capital trusts (VCTs).
Go toTop